Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | PHAS | GTBP | NEXI | ||
Company | Phasebio Pharmaceuticals Inc | GT Biopharma Inc | Neximmune Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.0800 | 2.72 | 2.49 | ||
High | 0.0920 | 2.86 | 2.49 | ||
Low | 0.0665 | 2.72 | 2.48 | ||
Last | 0.0701 | 2.75 | 2.48 | ||
Change | -0.0249 | -0.13 | unch | ||
% Change | -26.21% | -4.51% | unch | ||
Volume | 9,647,400 | 22,200 | 1,300 | ||
20-Day Average Volume | 3,930,150 | 74,735 | 8,020 | ||
Previous Close | 0.0950 | 2.88 | 2.48 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 0.1610 | 2.96 | 2.82 | ||
20-Day Raw Stochastic | 2.27% | 13.16% | 16.28% | ||
20-Day Relative Strength | 20.88% | 43.71% | 34.64% | ||
Weighted Alpha | -91.26 | -70.83 | -93.69 | ||
Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
Last Month's Opinion | 72% Sell | 88% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -42.40% since 10/26/22 | -9.39% since 06/26/24 | -10.14% since 06/26/24 | ||
Low | 0.0665 on 11/02/22 | 2.60 on 06/27/24 | 2.34 on 07/01/24 | ||
High | 0.1440 on 10/27/22 | 3.74 on 06/27/24 | 2.84 on 06/27/24 | ||
1-Month | |||||
%Chg | -60.17% since 09/30/22 | -22.86% since 06/03/24 | -20.00% since 06/03/24 | ||
Low | 0.0665 on 11/02/22 | 2.60 on 06/27/24 | 2.34 on 07/01/24 | ||
High | 0.2250 on 10/14/22 | 3.74 on 06/27/24 | 3.25 on 06/04/24 | ||
3-Month | |||||
%Chg | -93.85% since 08/02/22 | -40.86% since 04/03/24 | -50.89% since 04/03/24 | ||
Low | 0.0665 on 11/02/22 | 2.60 on 06/27/24 | 2.34 on 07/01/24 | ||
High | 1.3800 on 08/09/22 | 10.66 on 05/20/24 | 5.10 on 04/04/24 | ||
6-Month | |||||
%Chg | -94.35% since 05/02/22 | -64.33% since 01/03/24 | -60.00% since 01/03/24 | ||
Low | 0.0665 on 11/02/22 | 2.60 on 06/27/24 | 2.34 on 07/01/24 | ||
High | 1.3800 on 08/09/22 | 10.66 on 05/20/24 | 28.69 on 01/30/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 3,495 | 3,896 | 3,400 | ||
Shares Outstanding, K | 49,858 | 1,417 | 1,371 | ||
Annual Sales | 10,830,000 | 0 | 0 | ||
Annual Net Income | -131,070,000 | -7,600,000 | -32,340,000 | ||
Last Quarter Sales | 210,000 | 0 | 0 | ||
Last Quarter Net Income | -16,670,000 | -2,270,000 | -3,080,000 | ||
60-Month Beta | 2.57 | 0.65 | 1.91 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.34 on 08/12/22 | -2.12 on 05/15/24 | -2.21 on 05/20/24 | ||
Latest Earnings Date | 11/09/22 | 08/05/24 | 08/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |